Helus Pharma share price logo

Helus Pharma

NASDAQ: HELP

Small Cap

$10.55

-0.50

(-4.52%)

as on

Helus Pharma Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $10.38
    $10.96
    downward going graph

    1.61%

    Downside

    3.89%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Helus Pharma share price movements today

Previous Close
$11.05
Open
$10.89
Volume
1.3M
Market Cap
$807.4M
Day's Low - High
$10.38 - $10.96

Helus Pharma Historical Returns

1 Month Return
-24.75 %
3 Month Return
+ 45.52 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Helus Pharma Stock Fundamentals & Key Indicators

Check Helus Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$807.4M

EPS (TTM)

-5.51

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.62

Industry PE ratio

-6.86

PEG Ratio

-0.12

EBITDA

-177.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-74.47%

Helus Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Helus Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Helus Pharma image
Helus Pharma
StrongBuy$807.4MNA-2.620.00%0.00%
Moderna image
Moderna
Neutral$94.4B-32.76%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.9B174.93%29.3786.04%0.00%
Regeneron image
Regeneron
Buy$80.1B42.93%19.0184.86%0.46%

Analyst Recommendation on Helus Pharma Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Helus Pharma. Average target price of $48.6

Helus Pharma Share Price Target

Get share price movements and forecasts by analysts on Helus Pharma.

Current Price

$10.55

Analyzed by

5 Analysts

High

$70

0

Low

$22

Helus Pharma target price $0, a slight upside of 0% compared to current price of $10.55. According to 5 analysts rating.

Indian Investors' Interest in Helus Pharma Stock

Search interest for Helus Pharma Stock has increased by 182% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:182% versus previous 30 day period

Helus Pharma Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
0
Operating Income
-27
-25
-14
-57
-32
-24
-40
-41
-47
-47
EBITDA
-26
-25
-14
-57
-32
-24
-40
-41
-47
-47
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-30
-21
-10
-56
-10
-24
-47
-42
-46
-46
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-30
-21
-10
-56
-10
-24
-47
-42
-46
-46
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Helus Pharma Annual Profit & Loss

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Jun 2025
Mar 2026
Total Revenue
-
-
-
-
0
0
0
-
0
-44
Gross Profit
-
-
-
-
0
-
-
-
-
-44
Operating Income
0
0
0
-1
-31
-63
-51
-78
-143
-141
EBITDA
0
0
0
0
-30
-63
-51
-78
-
-141
Interest Expense
-
-
-
-
0
-
-
-
-
-
Depreciation
-
-
-
1
0
0
0
0
-
0
Income Before Tax
0
0
0
-1
-32
-67
-47
-78
-113
-57
Income Tax Expense
-
-
-
-
-
0
0
-
0
89
Net Income
0
0
0
-1
-32
-67
-47
-78
-113
-147
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
23.15%
0.00%
0.00%
0.00%
0.00%
100.27%

Helus Pharma Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-30
-21
-10
-56
-10
-18
-47
-42
-46
-46
Operating Cash Flow
-26
-20
-19
-25
-26
-21
-48
-31
-36
-36
Investing Cash Flow
7
0
0
0
0
0
0
0
0
0
Financing Cash Flow
39
190
0
0
0
40
0
143
0
45
Change in Cash
20
169
-20
-26
-28
18
-48
111
-36
8

Helus Pharma Annual Cash Flow

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Jun 2025
Mar 2026
Net Income
0
0
0
0
-32
-67
-47
-78
-113
-147
Operating Cash Flow
0
0
0
0
-19
-45
-47
-68
-101
-132
Investing Cash Flow
0
0
0
0
-1
0
-3
6
-1
-1
Financing Cash Flow
0
0
-
0
82
35
13
254
20
196
Change in Cash
0
0
0
0
62
-10
-37
192
-73
63

Global Institutional Holdings in Helus Pharma

Check out the Institutions with significant holdings in Helus Pharma.

Funds
Holdings
AdvisorShares
0.49%
Chuck Royce
0.32%
Fidelity
0.04%
State Street
0.04%
Kenneth Tropin
0.03%
See all

Helus Pharma News & Key Events

  • img

    Today's Timeline - 15 October

    Thu, 08:40 PM

    -

    Helus Pharma appoints Suresh Durgam, M.D., to its Board of Directors, enhancing governance and strategy for CNS programs.

Insights on Helus Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, HELP stock has moved up by 45.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 200.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 663.2%

About Helus Pharma

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
OrganisationHelus Pharma
Headquarters100 King Street West, Suite 5600, Toronto, ON, M5X 1C9, CA
IndustryMedical - Pharmaceuticals
CEOMichael I. Halstead

Key Management of Helus Pharma

Name

Title

Mr. Aaron Bartlone

Chief Operating Officer

Dr. Amir Inamdar FFPM, MBBS

Chief Medical Officer

Mr. Michael I. Halstead J.D.

CEO & Director

Ms. Lori Challenger

Chief Compliance, Ethics & Administrative Officer

Mr. Eric So L.L.B.

Co-Founder, President & Executive Chairman

Mr. Paul Glavine

Co-Founder, Chief Growth Officer & Director

Mr. Greg Cavers

Chief Financial Officer

Mr. John Kanakis

Co-Founder

Dr. Alex L. Nivorozhkin Ph.D.

Chief Scientific Officer

Mr. Gabriel Fahel

Chief Legal Officer & Corporate Secretary

FAQs

What is Helus Pharma share price today?

Helus Pharma share price today is $10.55 as on at the close of the market. Helus Pharma share today touched a day high of $10.96 and a low of $10.38.

What is the 52 week high and 52 week low for Helus Pharma share?

Helus Pharma share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Helus Pharma stock price today i.e. is closed at $10.55,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Helus Pharma's market capitalisation today?

Helus Pharma market capitalisation is $0.00T as on .

How to invest in Helus Pharma Stock (HELP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Helus Pharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Helus Pharma Stock (HELP) from India?

Indian investors can start investing in Helus Pharma (HELP) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Helus Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Helus Pharma share’s latest price of $10.55 as on October 17, 2026 at 8:46 am IST, you will get 0.9479 shares of Helus Pharma. Learn more about fractional shares .